STAR

Strides Pharma Science Share Price

 

 

Start SIP in STAR

Start SIP

Performance

  • Low
  • ₹897
  • High
  • ₹909
  • 52 Week Low
  • ₹513
  • 52 Week High
  • ₹1,025
  • Open Price₹906
  • Previous Close₹900
  • Volume40,152

Investment Returns

  • Over 1 Month + 2.35%
  • Over 3 Month + 9.56%
  • Over 6 Month -0.07%
  • Over 1 Year + 36.34%

Smart Investing Starts Here Start SIP with Strides Pharma Science for Steady Growth!

Invest Now

Strides Pharma Science Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 20.9
  • PEG Ratio
  • 0.3
  • Market Cap Cr
  • 8,287
  • P/B Ratio
  • 3
  • Average True Range
  • 30.24
  • EPS
  • 47.3
  • Dividend Yield
  • 0.4
  • MACD Signal
  • 4.89
  • RSI
  • 49.05
  • MFI
  • 74.11

Strides Pharma Science Financials

Strides Pharma Science Technicals

EMA & SMA

Current Price
₹899.05
-1.3 (-0.14%)
pointer
  • Bearish Moving Average 10
  • Bullish Moving Average 6
  • 20 Day
  • ₹906.67
  • 50 Day
  • ₹896.29
  • 100 Day
  • ₹878.82
  • 200 Day
  • ₹865.09

Resistance and Support

904.73 Pivot Speed
  • R3 932.77
  • R2 924.88
  • R1 912.62
  • S1 892.47
  • S2 884.58
  • S3 872.32

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Strides Pharma Science Ltd. is a global pharmaceutical company engaged in the development, manufacturing, and marketing of generic drugs. It focuses on niche therapeutic segments, including anti-retrovirals, oncology, and central nervous system, serving markets worldwide.

Strides Pharma Science has an operating revenue of Rs. 4,684.63 Cr. on a trailing 12-month basis. An annual revenue growth of 13% is good, Pre-tax margin of 11% is healthy, ROE of 140% is exceptional. The company has a reasonable debt to equity of 22%, which signals a healthy balance sheet. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 11% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. It is currently FORMING a base in its weekly chart and is trading around 11% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 53 which is a POOR score indicating inconsistency in earnings, a RS Rating of 84 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 56 indicates it belongs to a fair industry group of Medical-Generic Drugs and a Master Score of B is close to being the best. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Strides Pharma Science Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-10-31 Quarterly Results
2025-07-29 Quarterly Results
2025-05-22 Audited Results & Final Dividend
2025-01-30 Quarterly Results
2024-10-24 Quarterly Results
Date Purpose Remarks
2025-07-22 FINAL Rs.4.00 per share(40%)Final Dividend
2024-09-09 FINAL Rs.2.50 per share(25%)Final Dividend
2023-08-04 FINAL Rs.1.50 per share(15%)Final Dividend
2021-08-06 FINAL Rs.2.50 per share(25%)Final Dividend
View Strides Pharma Science Dividend History Arrow

Strides Pharma Science F&O

Strides Pharma Science Shareholding Pattern

27.86%
8.48%
2.94%
28.51%
0.01%
22.43%
9.77%

About Strides Pharma Science

  • NSE Symbol
  • STAR
  • BSE Symbol
  • 532531
  • Managing Director & Group CEO
  • Mr. Badree Komandur
  • ISIN
  • INE939A01011

Similar Stocks to Strides Pharma Science

Strides Pharma Science FAQs

Strides Pharma Science share price is ₹899 As on 01 January, 2026 | 11:28

The Market Cap of Strides Pharma Science is ₹8286.8 Cr As on 01 January, 2026 | 11:28

The P/E ratio of Strides Pharma Science is 20.9 As on 01 January, 2026 | 11:28

The PB ratio of Strides Pharma Science is 3 As on 01 January, 2026 | 11:28

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23